• Nano-Code: 2020-1-BG01-KA226-HE-095017
Partnership Area
What are you looking for?

he-lp8

HE Undergraduates in nanotechnology (EQF 8):

HE-LP8Nanotechnology in detection, diagnosis and treatment of SARS-CoV-2
SummaryThis training unit provides information about nanomaterials as excellent candidates against CoVs infections because of their particular features that allow instant, precise, and quick detection of contagious agents and their accurate and rapid treatment. The advances of nanotechnology in offering precise, sensitive, and fast diagnostic tools to detect infection at an early stage of its development are described. The training unit deals with the offers of modern nanotechnology comprising a variety of high-tech solutions for the prevention of infection, diagnostics, post-exposure prophylaxis, as well as effective treatments in cases when SARS-CoV-2-related disease has already developed. Information is presented concerning the novel nanotechnology-based biosensors, diagnostic devices, antiviral drugs, and vaccines that have been developed or repurposed to combat the modern pandemic.
ULOs
Knowledge & Skills		Upon completion of HE-LP8 the trainee will be able to:
  • Describe the current methods of detection of SARS-CoV-2;
  • Define the properties and categories of nanomaterials for SARS-CoV-2 detection;
  • Understand the differences between nanomaterials;
  • Demonstrate the main challenges and limitations of nanomaterials;
  • Discuss the application of nanomaterials for SARS-CoV-2 detection.
  • List the current laboratory methods for diagnosis of SARS-CoV-2;
  • Understand the categories of nanotechnology (nano biosensors, point-of-care testing and nanopore target sequencing);
  • Identify the differences between nano biosensors;
  • Illustrate the main challenges and limitations of nanotechnology in COVID-19;
  • Discuss the application of nanotechnology for diagnosis of SARS-CoV-2.
  • Present general information about the vaccines and treatments for COVID-19: causality, pathogenesis, and potential approaches to decrease the burden of COVID-related complications;
  • Reveal nano insights into treatment and prevention of COVID-19: application of nanomaterials for prevention of transmission and in the diagnostics of SARS-CoV-2;
  • Know the current therapeutics research achievements in nanotechnology to combat COVID-19;
  • Make an overview of nanoparticles’ vaccines.
  • Emphasize the SARS-CoV-2 and COVID-19 effects on thinking in research and clinical medicine;
  • Know the current developments of versatile nano-scale carrier platforms;
  • Explain the principles of construction and operation of the nano-based delivery systems for antiviral drugs;
  • Make an overview of the nanoformulations developed for the delivery of antiviral drugs;
  • Present the use of viral capsids for drug delivery.
CompositionLO 3.1. Nanomaterials in design and application of SARS-CoV-2 detection methods
LO 3.2. Nanotechnology in diagnostic techniques for SARS-CoV-2
LO 4.1. COVID-19 therapeutics: nanotechnology in antiviral treatments and vaccines
LO 4.2. New platforms to control viral infections: nano-scale carriers and drug delivery systems
(Self)AssessmentHE-LP8 Test
Credit points6
ValidationCertificate
This project has been funded with support from the European Commission. This web-site reflects the views only of the authors, and the Commission cannot be held responsible for any use which may be made of the information contained therein.